Rottenstein Law Group Produces Videos to Inform Public About Paxil History, Dangers, and Litigation
NEW YORK, Sept. 9, 2011 /PRNewswire/ -- The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the antidepressant Paxil, has produced a series of brief videos specifically intended to educate the public about the history of Paxil, possible dangers to those who take it, and litigation concerning the drug.
The Rottenstein Law Group recently launched a Paxil lawsuit resource website, www.paxilbirthdefectlaw.com, with features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, to enable visitors to spread the word about Paxil and the possible dangers of the drug. RLG has now made available at the site videos produced by the firm to educate the public. In keeping with the goal of maximum accessibility of the site, the videos can be downloaded by visitors and viewed on all manner of devices, including smart phones.
Studies have linked Paxil to numerous birth defects in children born to mothers who were taking the drug while pregnant. These include: clubbed foot; cleft lip/palate; delayed development; persistent pulmonary hypertension; gastroschisis; heart defects; skull defects; and brain/spinal cord defects. Moreover, it has been suggested that Paxil can cause premature birth or even miscarriage, and that a child exposed to Paxil in utero can experience withdrawal symptoms after birth.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients in consumer product injury, mass tort, and class action lawsuits in a compassionate manner. http://www.rotlaw.com
SOURCE The Rottenstein Law Group
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.